ATE189262T1 - Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen - Google Patents
Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE189262T1 ATE189262T1 AT93114084T AT93114084T ATE189262T1 AT E189262 T1 ATE189262 T1 AT E189262T1 AT 93114084 T AT93114084 T AT 93114084T AT 93114084 T AT93114084 T AT 93114084T AT E189262 T1 ATE189262 T1 AT E189262T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- pharmaceutical compositions
- binding protein
- interferon alpha
- beta binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL103052A IL103052A (en) | 1992-09-03 | 1992-09-03 | Soluble interferon-alpha receptors,their preparation and pharmaceutical compositions containing them |
IL106591A IL106591A (en) | 1992-09-03 | 1993-08-04 | Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE189262T1 true ATE189262T1 (de) | 2000-02-15 |
Family
ID=26322502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93114084T ATE189262T1 (de) | 1992-09-03 | 1993-09-02 | Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0588177B1 (de) |
JP (3) | JP3662264B2 (de) |
AT (1) | ATE189262T1 (de) |
AU (1) | AU674523B2 (de) |
CA (1) | CA2105449C (de) |
DE (1) | DE69327693T2 (de) |
DK (1) | DK0588177T3 (de) |
ES (1) | ES2142840T3 (de) |
GR (1) | GR3032891T3 (de) |
IL (1) | IL106591A (de) |
PT (1) | PT588177E (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL108584A (en) * | 1994-02-07 | 2008-03-20 | Yeda Res & Dev | Cloning of the interferon-binding protein ALPHA / BETA |
US5821078A (en) | 1992-09-03 | 1998-10-13 | Yeda Research And Development Co. Ltd. | Nucleic acid encoding interferon-α/β binding protein |
IL107378A (en) * | 1993-10-24 | 2005-05-17 | Yeda Res & Dev | SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE |
IL118096A0 (en) * | 1996-05-01 | 1996-09-12 | Yeda Res & Dev | Antibodies against interferon alpha/beta receptor |
WO1998006431A2 (en) * | 1996-08-16 | 1998-02-19 | Osther Kurt B | Method for treating diabetes |
DE69731983T2 (de) * | 1996-08-19 | 2005-10-06 | Shaker, Ghassan I. | Verwendung von molt4 cd69 expression zur bestimmung der anwesenheit und der aktivität von interferoninhibitoren |
ES2174530T3 (es) | 1997-12-19 | 2002-11-01 | Applied Research Systems | Complejo ifnar/ifn. |
US20070081995A1 (en) * | 2005-06-22 | 2007-04-12 | Genentech, Inc. | Methods and compositions for targeting IFNAR2 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL88377A (en) * | 1988-11-14 | 1996-09-12 | Yeda Res & Dev | Cloning and expression of a protein which modulates cellular response to type I interferon |
FR2657881A1 (fr) * | 1990-02-05 | 1991-08-09 | Europ Biotechnologie Lab | Nouveaux polypeptides hydrosolubles, sequences d'adn, nouvelles cellules, procede de preparation, applications et compositions renfermant lesdits polypeptides. |
-
1993
- 1993-08-04 IL IL106591A patent/IL106591A/en not_active IP Right Cessation
- 1993-09-02 EP EP93114084A patent/EP0588177B1/de not_active Expired - Lifetime
- 1993-09-02 CA CA2105449A patent/CA2105449C/en not_active Expired - Lifetime
- 1993-09-02 JP JP24398793A patent/JP3662264B2/ja not_active Expired - Lifetime
- 1993-09-02 PT PT93114084T patent/PT588177E/pt unknown
- 1993-09-02 DK DK93114084T patent/DK0588177T3/da active
- 1993-09-02 DE DE69327693T patent/DE69327693T2/de not_active Expired - Lifetime
- 1993-09-02 ES ES93114084T patent/ES2142840T3/es not_active Expired - Lifetime
- 1993-09-02 AU AU46096/93A patent/AU674523B2/en not_active Expired
- 1993-09-02 AT AT93114084T patent/ATE189262T1/de active
-
2000
- 2000-03-07 GR GR20000400586T patent/GR3032891T3/el unknown
-
2004
- 2004-03-25 JP JP2004090279A patent/JP2004254695A/ja active Pending
-
2005
- 2005-01-12 JP JP2005004934A patent/JP3907661B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69327693D1 (de) | 2000-03-02 |
AU4609693A (en) | 1994-03-10 |
PT588177E (pt) | 2000-05-31 |
DK0588177T3 (da) | 2000-05-08 |
EP0588177B1 (de) | 2000-01-26 |
JP3907661B2 (ja) | 2007-04-18 |
CA2105449A1 (en) | 1994-03-04 |
IL106591A0 (en) | 1993-12-08 |
CA2105449C (en) | 2010-07-20 |
AU674523B2 (en) | 1997-01-02 |
EP0588177A3 (en) | 1994-08-17 |
ES2142840T3 (es) | 2000-05-01 |
JP2005162762A (ja) | 2005-06-23 |
JP2004254695A (ja) | 2004-09-16 |
EP0588177A2 (de) | 1994-03-23 |
GR3032891T3 (en) | 2000-07-31 |
IL106591A (en) | 2008-03-20 |
DE69327693T2 (de) | 2000-09-07 |
JP3662264B2 (ja) | 2005-06-22 |
JPH06220100A (ja) | 1994-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0497904A4 (en) | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use | |
DE68912237T2 (de) | Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung. | |
MX9202839A (es) | 4-aminoquinolinas y composiciones farmaceuticas de las mismas. | |
IL85609A0 (en) | Phenyl carbamate,its preparation and pharmaceutical compositions containing it | |
DE69021387T2 (de) | Medizinische aerosolformulierungen. | |
DE3769458D1 (de) | Physiologisch wirksame und naehrende zusammensetzung. | |
IL92937A0 (en) | Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it | |
DE69012702T2 (de) | Dentalzusammensetzung. | |
IT8820386A0 (it) | Composizioni farmaceutiche orosolubili contenti acetilcisteina. | |
IT9019754A0 (it) | Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica | |
DE3579730D1 (de) | Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen. | |
MX9204240A (es) | Montaje distribuidor y de mezclado de dos etapas para preparaciones tal como cementos dentales. | |
IT1224574B (it) | Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono | |
ATE189262T1 (de) | Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen | |
ATE67783T1 (de) | Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen. | |
DE69009795T2 (de) | Muramylpeptid-Derivate und diese enthaltende immunregulierende Zusammensetzungen. | |
DE68905973T2 (de) | Synergistische suessungsmittel-zusammensetzungen, enthaltend chlorodeoxysucrase, und diese enthaltende zusammensetzungen. | |
KR950701629A (ko) | 신규한 탁산 유도체, 그의 제법 및 그를 함유하는 조성물(Novel taxane derivatives, their preparation and compositions containing same) | |
DE59208622D1 (de) | Dentalwerkstoffe auf Basis von (Meth)-Acrylaten | |
EE9400337A (et) | Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused | |
ATE74589T1 (de) | Durch (omega-amino)-alkanolgruppen substituierte aromatische derivate mit antimikrobenwirkung und diese enthaltende zusammensetzungen. | |
DE3761561D1 (de) | N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3871159D1 (de) | Pharmazeutische und tieraerztliche zusammensetzungen. | |
FI920845A0 (fi) | Farmaceutiska kompositioner innehaollande interleukin-2. | |
DE3869232D1 (de) | Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |